EV/EBITDA
-0.65
-0.02-3.17%
Fri, 03 Jan 2025 23:34:31 GMT
Summary:
Qualigen Therapeutics EV/EBITDA is currently -0.65, with a fall of -0.02 (-3.17%) during the most recent trading day. Over the past year, it has dropped by -0.30 (-85.71%). QLGN EV/EBITDA is now -1525.00% below its all-time high of -0.04.QLGN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | -3.2% |
1 m1 month | 0.0% |
3 m3 months | +19.8% |
6 m6 months | -66.7% |
ytdytd | -6.6% |
1 y1 year | -85.7% |
5 y5 years | - |
QLGN EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -0.56 | -16.1% | -0.67 | +3.0% |
3 m | 3 months | -0.55 | -18.2% | -0.90 | +27.8% |
6 m | 6 months | -0.39 | -66.7% | -0.90 | +27.8% |
1 y | 1 year | -0.20 | -225.0% | -0.90 | +27.8% |
3 y | 3 years | -0.04 | -1525.0% | -1.16 | +44.0% |
5 y | 5 years | -0.04 | -1525.0% | -6.61 | +90.2% |
alltime | all time | -0.04 | -1525.0% | -6.61 | +90.2% |
Qualigen Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -0.65(+6.6%) |
2024 | -0.61(+74.3%) |
2023 | -0.35(+118.8%) |
Date | Value |
---|---|
2022 | -0.16(-83.7%) |
2021 | -0.98(-62.5%) |
2020 | -2.61 |
FAQ
- What is Qualigen Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Qualigen Therapeutics?
- What is QLGN EV/EBITDA year-to-date change?
- What is Qualigen Therapeutics EV/EBITDA year-on-year change?
What is Qualigen Therapeutics EV/EBITDA?
The current EV/EBITDA of QLGN is -0.65
What is the all time high EV/EBITDA for Qualigen Therapeutics?
Qualigen Therapeutics all-time high EV/EBITDA is -0.04
What is QLGN EV/EBITDA year-to-date change?
Qualigen Therapeutics EV/EBITDA has changed by -0.04 (-6.56%) since the beginning of the year
What is Qualigen Therapeutics EV/EBITDA year-on-year change?
Over the past year, QLGN EV/EBITDA has changed by -0.30 (-85.71%)